FREMONT, Calif. - Ichor Holdings, Ltd. (NASDAQ:ICHR), a company specializing in the design, engineering, and manufacturing of critical fluid delivery subsystems for semiconductor capital equipment, has initiated a public offering of its ordinary shares amounting to $125 million.
The firm also plans to offer underwriters a 30-day option to purchase an additional 15% of the shares at the public offering price, minus underwriting commissions.
The net proceeds from the offering are earmarked for the repayment of existing debt and general corporate purposes, which may include capital expenditures, potential acquisitions, growth opportunities, and strategic transactions.
TD (TSX:TD) Cowen and Stifel are leading the offering as joint book-running managers. B. Riley Securities, Needham & Company, Craig-Hallum, and D.A. Davidson & Co. are serving as co-managers.
The offering is based on a shelf registration statement on Form S-3 filed with the Securities and Exchange Commission (SEC) on August 9, 2023, which became effective immediately. A preliminary prospectus supplement detailing the offering terms was filed with the SEC on March 12, 2024, and is accessible on the SEC's website.
Investors are encouraged to review the investment details, risks, charges, and expenses of Ichor Holdings before investing. The preliminary prospectus supplement and the accompanying base prospectus contain important information about the company and are recommended for careful reading before making any investment.
This press release does not constitute an offer to sell or a solicitation of an offer to buy any securities, and there will be no sale of the securities mentioned in any state or jurisdiction where such an offer, solicitation, or sale would be illegal before registration or qualification under the securities laws of such state or jurisdiction.
Ichor Holdings, based in Fremont, CA, is a recognized leader in its field, providing fluid delivery subsystems to the semiconductor industry as well as serving sectors like defense/aerospace and medical.
The information in this article is based on a press release statement from Ichor Holdings, Ltd.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.